RETIN-A GEL Rx
Generic Name and Formulations:
Tretinoin 0.01%, 0.025%; alcohol 90%.
Valeant Pharmaceuticals, Inc
Indications for RETIN-A GEL:
Apply sparingly at bedtime to clean dry skin; adjust strength and frequency as tolerated and needed.
Not for use in eczema or sunburned skin. Avoid eyes, mouth, angles of nose, mucous membranes, sun, UV light. Discontinue if sensitivity reactions occur. Increased irritation in weather extremes. Gel: flammable. Pregnancy (Cat.C): not recommended. Nursing mothers.
Caution with concomitant topical medication, medicated or abrasive soaps/cleansers, astringents, drying agents, high-alcohol content topical products, spices. Avoid contact with peel of limes. Allow effects of benzoyl peroxide, sulfur, resorcinol, salicylic acid, other topical acne agents to subside before applying.
Local irritation, skin pain, pruritus, pharyngitis, erythema, transient symptom exacerbation or pigmentation changes, dryness, stinging, photosensitivity.
Micro 0.04%, 0.1%—20g, 45g, 50g; 0.08%—50g; Crm—20g, 45g; Gel—15g, 45g; Liq—28mL
Clinical Pain Advisor Articles
- Cannabis Use High in Migraine
- Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Percutaneous Electrolysis May Be Useful Adjunct for Subacromial Pain Syndrome
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use